International Journal of Epidemiology 2001;30:588-589
© International Epidemiological Association 2001
Infectious Disease |
Commentary: Developing preventive strategies in Europe
ZAPP, 103105 Rotten Row, Harare, Zimbabwe. Present address: Department of Sexually Transmitted Diseases, University College London, Mortimer Market Centre, Crapper Street,London, UK. E-mail:fcowan@gum.ucl.ac.uk
With the recent increase in availability of relatively cheap and sensitive type-specific antibody tests for Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), the sero-epidemiology of these infections in different countries around the world is becoming better defined. Studies demonstrate wide variation in HSV seroprevalence according to geographical location, socioeconomic and behavioural factors.1 This study from the University Hospital in Rotterdam, Holland is interesting in
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Xu, M. R. Sternberg, B. J. Kottiri, G. M. McQuillan, F. K. Lee, A. J. Nahmias, S. M. Berman, and L. E. Markowitz Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA, August 23, 2006; 296(8): 964 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Tran, J D Druce, M C Catton, H Kelly, and C J Birch Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003 Sex. Transm. Inf., August 1, 2004; 80(4): 277 - 279. [Abstract] [Full Text] [PDF] |
||||

